Abbott (NYSE:ABT) said its board of directors approved the spinout of its branded pharmaceuticals business as AbbVie Inc. in which Abbott’s shareholders will receive an AbbVie share for each ABT share they own.
The distribution is slated for Jan. 1, 2013, for shareholders of record as of Dec. 12, according to a press release.
MASSDEVICE ON CALL — Rep. Peter Roskam (R-Ill.) dedicated his latest "Ask Peter" video to warning viewers about the impact the medical device tax could have on jobs in Illinois and asking viewers to make their voices heard through emails, calls and letters to his office.
Boston Scientific (NYSE:BSX) executive vice president and chief financial officer Jeffrey Capello joined the board of directors at OvaScience, a Boston, Mass.-based start up developing infertility treatments.
Capello began working at Boston Scientific in 2008, landing the CFO seat in 2010. He oversees the company’s global finance, information systems, business development and corporate strategy functions.
MassDevice Network
@MassDevice
LinkedIn
YouTube